78 results about "Anterior rhinorrhea" patented technology

The present invention relates to compositions comprising an antitussive, a decongestant and an expectorant, and in a specific embodiment comprising hydrocodone, phenylephrine hydrochloride and guaifenesin, wherein the composition may be substantially free of added sugar and added alcohol, and methods for using these compositions for the treatment of patients suffering from, for example and without limitation, coughing, sneezing, rhinorrhea, and/or nasal obstruction.

A solid pharmaceutical dosage unit for alleviating the symptoms of rhinorrhea. The dosage unit comprises an anticholinergic agent and an antihistamine and, optionally, a decongestant and, when placed in a basket in 500 ml of 0.01 N HCl of 37° C. which is stirred at 100 rpm, releases at least about 75% of the at least one anticholinergic agent within 45 minutes and releases the at least one antihistamine at a rate of from about 20% to about 60% after 2 hours, from about 45% to about 80% after 4 hours and at least about 75% after 8 hours. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way.

New stable compositions comprising the combination of a topically active vasoconstrictor and a topically active anticholinergic drug are disclosed. Preferably, the composition comprises ipratropium or a salt thereof in combination with xylometazoline hydrochloride and a salt thereof. Upon topically administering such compositions to a nasal mucosa in individuals suffering from the common cold the symptoms of rhinorrhea are significantly reduced.

The present invention relates to compositions that comprise an expectorant, an extended release antitussive, and an extended release decongestant, in liquid. Specifically, the compositions may comprise guaifenesin, and the tannate salts of phenylephrine and dextromethorphan. The present invention also includes methods for using these compositions for treatment of patients suffering from, for example and without limitation, coughing, sneezing, rhinorrhea, and/or nasal obstruction.

An oral disintegrating tablet of dextromethorphan for treating the cold caused cough, nasal congestion and rhinorrhea is proportionally prepared from dextromethorphan, chlorphenamine, pseudoephedrine, beta-cyclodextrin or ion exchange resin, mannitol or lactose starch, and disintegrant through sieving, flavouring, mixing and die pressing.

The invention discloses violet magnolia rhinitis powder which comprises the following crude drugs in parts by weight: 20 parts of violet magnolia, 60 parts of dahurian patrinia herb, 300 parts of mint, 200 parts of perilla leaves, 400 parts of liquorice, 500 parts of pogostemon cablin, 500 parts of cocklebur fruit, 18 parts of centipeda minima, 100 parts of coptis chinensis, 200 parts of elecampane, 150 parts of ledebouriella seseloides, 150 parts of houttuynia cordata, 280 parts of chrysanthemum, 360 parts of evodia lepta, 30 parts of catechu, 120 parts of indigo naturalis, 50 parts of euphorbia kansui and 25 parts of radix puerariae. The violet magnolia rhinitis powder is scientifically prepared from pure Chinese medicinal herbs and has the effects of expelling wind and removing heat, diminishing inflammation and detoxifies and can be used for treating rhinitis, influenza and rhinorrhea and nasal congestion without relapsing. The violet magnolia has the characteristics of convenient taking, less dosage and favorable curative effect, high total effective rate of more than 99 percent and high effectual rate of more than 95 percent.

The invention discloses a medicine composition for treating rhinitis, and the composition consists of felwort, cocklebur fruit, flower bud of lily magnolia, pseudosciaena crocea, euphorbia kansui, asarum, muskmelon pedicel, dried alum, indigo naturalis, acacia catechu, manyleaf paris rhizome, radices trichosanthis, thunberg fritillary bulb, Guangdong radix curcumae, caulis spatholobi, albizia flower, platycodon grandiflorum, common hogfenneI root, fructus viticis, burdock, smoked plum, fructus rosae laevigatae, semen cuscutae and caulis clematidis armandii. The medicine composition disclosed by the invention is added with general auxiliary materials according to general technique so as to be prepared into clinically acceptable pellet, capsule, slice, particle, powder, decoction or oral liquid. The medicine composition disclosed by the invention has the effects of clearing heat and toxic materials, removing wind, strengthening exterior and curing nasal obstruction, has remarkable effects for treating nasosinusitis, nasal obstruction, rhinorrhea, ache of forehead, rhinitis, nasosinusitis and anaphylactic rhinitis, and causes no toxic and side effects.

The invention relates to an anti-cold medical composition consisting of active components of loratadine, acetaminophen, pseudoephedrine sulfate and pharmaceutically acceptable auxiliary materials. The medical composition is a double-layered sustained-release tablet with a quick release outer layer coating a sustained-release core. The quick release outer layer comprises loratadine and pseudoephedrine sulfate while the sustained-release part comprises acetaminophen and pseudoephedrine sulfate. The double-layered composition is used for relieving sneeze, rhinorrhea, nasal obstruction, laryngeal discomfort, weakness, fever, sore muscle, headache and the like which are caused by cold or seasonal allergic rhinitis.

The present invention relates to compositions that comprise immediate release and extended release guaifenesin, and extended release hydrocodone bitartrate. The present invention also includes methods for using these compositions for treatment of patients suffering from, for example and without limitation, coughing, sneezing, rhinorrhea, and/or nasal obstruction.

The invention relates to a loquat floral honey wine and the making method. The loquat floral honey wine is fermented with loquat floral 100 parts, sugar 80-120 parts, fermentation yeast 0.5-4.5 parts, water 200-320 parts and loquat honey 0-8 parts. The making method comprises the following procedures: proceeding with the first fermentation for 30-90 days in the sealable and germ-free tank after mixing the above material in the proper mixing condition; separating wine residue from fermented material and putting the separated wine liquid in the sealable and germ-free tank in order to deposit directly more than one month; proceeding with the second fermentation of the liquid without deposit in the sealable and germ-free tank at least one month. The loquat floral honey wine can be drank as the wine or beverage, which not only has aromatic odor, salubrious taste and pure wine flavour, but also can remove mental fatigue, and prevent or subsidiarily treat seborrheic and rhinorrhea disease and the like.

The invention relates to a drug for treating cold. The drug is prepared from the following ingredients in parts by weight: 40-60 parts of forsythia fruit, 40-60 parts of bupleurum root, 15-25 parts of licorice root, 25-35 parts of honeysuckle flower, 20-35 parts of Chuanxiong rhizome, 20-30 parts of black curded bean, 40-60 parts of dandelion, 15-25 parts of lysionotus pauciflorus, 25-35 parts of mint and 10-25 parts of herba schizonepetae. The drug has the effects of clearing heat and detoxifying, dispelling heat and moistening the lung and relieving cough, and is used for treating cold-induced symptoms, such as headache, fever, rhinorrhea, sneezing, coughing, muscle aches and the like. The drug is oral liquid, is a purely-natural traditional Chinese medicine, is free from toxic and side effects and is remarkable in effect.

The compound cold treating preparation is prepared with 11 kinds of Chinese medicinal materials including honeysuckle, mulberry leaf, forsythia, mint, burdock fruit, etc. as well as acetaminophen, and it may be prepared into granule, tablet, capsule, syrup, oral liquid, pill or ointment. The present invention is developed based on the features of wind-heat type common cold and influenza and has excellent curative effect on wind-heat type common cold and influenza with the syndromes of fever, headache, cough, swelling and pain throat, snuffle and rhinorrhea and no toxic side effect.

The invention provides a raindrop-type humidifier. The humidifier comprises a first water trough, at least one water receiving container, a second water trough and a connecting rod. Perforating holes are formed in the bottom of the at least one water receiving container and the bottom of the second water trough respectively, the at least one water receiving container is fixed to the connecting rod through the corresponding perforating hole, the second water trough is fixed to the connecting rod through the corresponding perforating hole, and a plurality of micro-holes are formed in the bottom of the at least one water receiving container and the bottom of the second water trough respectively. The connecting rod comprises an inner diameter channel. The inner diameter channel is higher than the bottom of the second water trough, a drainage tube is arranged in the inner diameter channel in a penetrating mode and connected with a water pump, and the water pump is arranged in the first water trough. By means of the raindrop-type humidifier in the technical scheme, it can be avoided that due to a spray humidification mode, the physiological reactions such as sneezing and rhinorrhea of an allergic constitution user appear, and the overall comfort degree of the user is improved.

The invention provides an anti-inflammatory compound extract comprising Li nationality medicinal materials including aerial parts of Ficus pumila L. and Elaeagnus gonyanthes Benth., its preparation method, and a Li nationality medicinal composition containing the active extract. The extract and composition can be used for treating headache, dizziness, rhinorrhea and nasal obstruction due to acute and chronic sinusitis; have no toxic and side effects; and can be prepared into any oral preparation for treating acute and chronic sinusitis.

The invention discloses a fumigation device for treating allergic rhinitis. The fumigation device for treating allergic rhinitis comprises a bottom supporting part, a heating part, a medicine accommodating part and a fumigation part; the heating part is fixedly arranged on the upper part of a bottom supporting part; the medicine accommodating part is detachably arranged on the upper part of the heating part; and the fumigation part is communicated with the upper part of the medicine accommodating part. The fumigation device provided by the invention is stable to use, not liable to break, highin heating efficiency and high in heating efficiency, can liberate double hands of patients, has high practicability, can adapt to the use requirements of different patients, is convenient to use at home and is also convenient to use in hospitals; the traditional Chinese medicine formula can effectively reduce symptoms of sternutation, rhinorrhea, nasal obstruction, itchy and feverish nasal cavityof patients; and the use method of the fumigation device is simple in use step and easy to operate, and the decocted traditional Chinese medicine has good effect of treating allergic rhinitis and greatly increases the healing rate of the allergic rhinitis of the patients.

The invention relates to medicine and a preparation method thereof, in particular to Mongolian medicine for treating Yamaa disease and a preparation method thereof. The Mongolian medicine is characterized by being composed of, by weight, 63-110 parts of radix aconiti kusnezoffii preparata, 36-120 parts of radix ophiopogonis and 36-100 parts of flos carthami. The Mongolian medicine is prepared by adopting modern processes including powdering and pilling or microwave radiation or solvent extraction. The Mongolian medicine has the advantages that radix ophiopogonis and flos carthami are utilizedto resist, offset or lower toxic and side effect of radix aconite kusnezoffii preparata, efficacy of radix aconite kusnezoffii preparata serving as main medicine on diminishing inflammation, relievingpain and eliminating yellow liquid is brought into full play, and auxiliary medicine having effects of relieving pain, clearing heat and is combined, so that the Mongolian medicine has remarkable treatment effect on symptoms like migraine and headache, toothache, eye rim pain, ocular disorder, rhinorrhea, red apex nasi, nasal cavity itching and difficult breathing caused by Yamaa disease; the Mongolian medicine is direct in efficacy, quick in action, few in toxic and side effect, safe to take, low in cost and considerable in popularization and application prospect.

The invention discloses a traditional Chinese medicine preparation for treating infantile hand-foot-mouth disease and a preparation method, belonging to the field of traditional Chinese medicines. The traditional Chinese medicine preparation is prepared from the following raw materials as effective ingredients: isatis root, smallfruit fig aerial root, carrot, viburnum dilatatum, ligustrum sinense, cortex dictamni, tamarisk, centella, stinkweed, chushan lip-fern herb, rhizoma cimicifugae, nutgall, mint, myricaria germanica, licorice and acacia catechu. The medicinal materials selected by the traditional Chinese medicine preparation are appropriate in compatibility and are combined to achieve the effects on clearing away heat and toxic materials, dispelling wind and arresting itching, strengthening superficial body resistance and promoting eruption, eliminating dampness and astringing sores, invigorating qi and strengthening the middle-jiao, relieving spasm and pain and the like; the traditional Chinese medicine preparation has the advantages of exact curative effect, high effect taking speed, high cure rate, no toxic or side effect, safety and reliability when used for treating symptoms, such as cough, herpes, herpes labialis, rhinorrhea, salivation, stomatalgia, corrosive blister, blister or bleb injury, meloschisis and tongue and gum painful miliary blister, caused by infantile hand-foot-mouth disease; and therefore, the traditional Chinese medicine preparation can be widely used for clinically treating infantile hand-foot-mouth disease.